top of page
Recent news
Archived news
Aug 20, 2020
New publication in MethodsX international journal
Detailed laboratory protocols, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
Aug 5, 2020
Patent for China
We have been informed by Chineese Patent Office that our patent application no 201580028495.1, concerning our break-through recombinant...
Jul 1, 2020
Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Jun 23, 2020
Scientific publication
Scientific publication in the area of industrial enzymes. A novel proteinase Onygena, an improved alternative to the ‘workhorse’ of...
May 28, 2020
Patent for Israel
We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA...
Apr 16, 2020
Patent for Japan
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Mar 20, 2020
Patent application for India
We have been informed by Indian Patent Office that our patent application no 201647039411, concerning our break-through recombinant DNA...
Dec 31, 2019
New publication in Data in Brief international journal
More technical details, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
Nov 13, 2019
New publication in Materials Science & Engineering C
The patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology,...
Aug 3, 2018
Patent for Republic of Poland
Our break-through recombinant DNA biotechnology for the construction of new generation vaccines, biologics, biosymilars, industrial and...
Apr 5, 2018
New scientific publication
New scientific publication, defining a new bacteriophage genus TP84 virus. The paper describes monographic work on TP-84 bacteriophage...
Nov 13, 2017
Establishing CLEARWING FOUNDATION FOR BIODIVERSITY
Our company and team members are environmentally conscious. BioVentures Institute’s patented technology has a potentially high impact on...
Jul 27, 2017
ClearWing Foundation for Biodiversity
Our company and team members are environmentally conscious. BioVentures Institute patented technology has potentially high impact on the...
Jul 1, 2017
Cooperation with University of Gdansk and New England Biolabs Ltd. (USA)
BioVentures InstituteSp. z o.o. continues a long term cooperation with University of Gdansk and New England Biolabs Ltd. (USA), a world...
Jan 2, 2017
The new grant issued
The new grant STRATEGMED TARGETTELO in the amount of 19 654 385.00 PLN issued by the National Center for Research and Development was...
Nov 2, 2016
Patent application to USA, EU, Israel, Japan, China, India
BioVentures Institute Sp. z o.o. has extended the international PCT patent application no WO 2015162560 A1, covering the technology of...
Feb 8, 2016
Business relationship with Israeli companies
BioVentures Institute established business relationships with several Israeli companies, as well as with the Israeli Ministry of Regional...
Feb 2, 2016
New “molecular scissors” for DNA cleavage
Cooperation in the area of engineering of enzyme performance for biotechnology purposes between BioVentures Institute Sp. z o. o. and ...
Oct 18, 2015
Cooperation agreement with Barentzymes AS
Barentzymes AS, a Norwegian biotechnology company (part of Fluenta holding) has signed a long term cooperation agreement with BioVentures...
Jun 1, 2015
Professor Piotr Skowron received the 1st award
Professor Piotr Skowron received the 1st award granted by the Pomeranian Employers Association in the category “Primum Cooperatio” i.e....
bottom of page